|
|
||||||||
Clinical Chemistry, Vol 33, 297-299, Copyright © 1987 by American Association for Clinical Chemistry
J Lemann Jr and BT Doumas
We measured daily excretion rates for urinary protein and the ratios of urinary protein to creatinine in 24-h urines and in untimed urines in 60 healthy adults, 30 patients with kidney disease, and 22 kidney- transplant recipients. The ratios for urinary protein/creatinine, mg/g, in untimed urines and in 24-h urines from the same subjects were closely correlated (r = 0.97) for rates of protein excretion ranging from normal (mean 44 mg/day) to nephrotic (maximum 19,300 mg/day). Because urinary protein/creatinine in healthy subjects never exceeded 100 mg/g, we propose that a ratio of less than 100 mg/g in untimed urines, obtained in the absence of exercise, fever, or other evidence of urinary tract disease, is a criterion of normal kidney function. Among patients with nephrotic syndrome (urinary protein excretion rate greater than or equal to 4000 mg/day), urinary protein/creatinine ratios always exceeded 2000 mg/g in both 24-h and untimed urines. Intermediate urinary protein/creatinine ratios (100 to 2000 mg/g) may reflect any type of kidney disease.
The following articles in journals at HighWire Press have cited this article:
![]() |
E. J Lamb, F. MacKenzie, and P. E Stevens How should proteinuria be detected and measured? Ann Clin Biochem, May 1, 2009; 46(3): 205 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Hong, K. Hughes, K.-S. Chia, V. Ng, and S.-L. Ling Urinary {alpha}1-Microglobulin as a Marker of Nephropathy in Type 2 Diabetic Asian Subjects in Singapore Diabetes Care, February 1, 2003; 26(2): 338 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. EL-Safty, M. Gadallah, A. Shafik, and A. E Shouman Effect of mercury vapour exposure on urinary excretion of calcium, zinc and copper: relationship to alterations in functional and structural integrity of the kidney Toxicology and Industrial Health, September 1, 2002; 18(8): 377 - 388. [Abstract] [PDF] |
||||
![]() |
K. Bashir and J. N. Whitaker Clinical and laboratory features of primary progressive and secondary progressive MS Neurology, September 1, 1999; 53(4): 765 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Remuzzi and T. Bertani Pathophysiology of Progressive Nephropathies N. Engl. J. Med., November 12, 1998; 339(20): 1448 - 1456. [Full Text] [PDF] |
||||
![]() |
P. Ruggenenti, F. Gaspari, A. Perna, and G. Remuzzi Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes BMJ, February 14, 1998; 316(7130): 504 - 509. [Abstract] [Full Text] |
||||
![]() |
E. A. Sasse, B. T. Doumas, and J. Lemann Jr. Diabetic Nephropathy: Urinary Albumin or Total Protein? Ann Intern Med, August 15, 1989; 111(4): 343 - 344. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |